Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort

BACKGROUND: : Systemic immunosuppressive treatments are central in the treatment of severe atopic dermatitis (AD). Yet, comparative data are sparse on the performance of such immunosuppressive treatments in pediatric cohorts with severe AD. OBJECTIVE: : This study aimed to examine the drug survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsgaard, Stine, Danielsen, Anna Kathrine, Thyssen, Jacob P., Deleuran, Mette, Vestergaard, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714597/
https://www.ncbi.nlm.nih.gov/pubmed/35028369
http://dx.doi.org/10.1016/j.ijwd.2021.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714597/
https://www.ncbi.nlm.nih.gov/pubmed/35028369
http://dx.doi.org/10.1016/j.ijwd.2021.07.005

Ejemplares similares